logo
Search orAI Icon𝛼SK
ENTITY
Shanghai Junshi Biosciences

Shanghai Junshi Biosciences (1877 HK)

271
Analysis
Health Care • China
Shanghai Junshi Biosciences Co., Ltd. operates as a biopharmaceutical company. The Company develops and sells small molecule drugs, antibody drug conjugates, and other products. Shanghai Junshi Biosciences markets its products worldwide.
more
Exchange Announcement • 14 Dec 2025 18:54

Voluntary Announcement - Fda Approval Of Investigational New Drug Application For Js212

Exchange Announcement • 10 Dec 2025 19:56

Overseas Regulatory Announcement - Shanghai Junshi Biosciences Co., Ltd.* Announcement On Progress Of The Increase In Shareholding By One Of The Controlling Shareholders, Actual Controllers And The Chairman Of The Board Of Directors

Exchange Announcement • 07 Dec 2025 18:17

Voluntary Announcement - New Indications Of Tuoyi And Junshida Have Been Included In The National Reimbursement Drug List

Exchange Announcement • 05 Dec 2025 20:32

Voluntary Announcement - Acceptance Of The New Drug Application For Roconkibart Injection

Exchange Announcement • 04 Dec 2025 19:22

Overseas Regulatory Announcement - Shanghai Junshi Biosciences Co., Ltd.* Announcement On The Result Of The Reduction In Shareholding Of The Shareholders Holding More Than 5% Of The Shares

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.10

x